Ergoteles LLC - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 712 filers reported holding VANECK VECTORS ETF TR in Q4 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2022$741,000
-95.2%
30,739
-94.6%
0.03%
-94.4%
Q2 2022$15,498,000
+16564.5%
566,024
+20595.6%
0.46%
+23100.0%
Q2 2021$93,000
-99.7%
2,735
-99.7%
0.00%
-99.8%
Q1 2021$27,580,000
+5856.8%
848,617
+6503.0%
0.86%
+5620.0%
Q4 2020$463,000
+26.8%
12,852
+37.8%
0.02%
-68.8%
Q3 2020$365,0009,3240.05%
Other shareholders
VANECK VECTORS ETF TR shareholders Q4 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$20,220,00066.82%
Baymount Management LP 145,000$3,970,00028.08%
New Harbor Financial Group, LLC 1,371,341$37,547,00018.51%
New Harbor Financial Group, LLC 1,291,700$35,366,00017.44%
MKP Capital Management, L.L.C. 1,500,000$41,070,00013.74%
Windmill Hill Asset Management Ltd 844,600$23,125,00011.94%
Hollow Brook Wealth Management LLC 768,567$21,043,00011.57%
Grand Central Investment Group 261,915$7,171,00010.33%
Point72 Europe (London) LLP 1,467,000$40,166,0008.50%
Slate Path Capital LP 4,600,000$125,948,0007.87%
View complete list of VANECK VECTORS ETF TR shareholders